Published in Carcinogenesis on July 01, 1998
The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions. J Cancer Res Clin Oncol (2005) 0.95
Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non-small-cell lung cancer and precursor lesions. Histopathology (2008) 0.94
Protein expression profiles indicative for drug resistance of non-small cell lung cancer. Br J Cancer (2002) 0.85
Inter-individual variation in DNA repair capacity: a need for multi-pathway functional assays to promote translational DNA repair research. DNA Repair (Amst) (2014) 0.81
Immunohistochemical Assessment of O(6)-Methylguanine-DNA Methyltransferase (MGMT) and Its Relationship with p53 Expression in Endometrial Cancers. J Cancer Prev (2013) 0.80
Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo. Virology (2015) 0.80
Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer (1996) 1.84
Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer (1997) 1.51
Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy. Eur J Cancer (1979) 1.49
Immunohistochemical detection of the multi-drug-resistance marker P-glycoprotein in uterine cervical carcinomas and normal cervical tissue. Am J Obstet Gynecol (1992) 1.43
Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res (2000) 1.43
P-glycoprotein expression in treated and untreated human breast cancer. Br J Cancer (1989) 1.39
Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy. J Clin Oncol (2001) 1.18
Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int J Cancer (1998) 1.18
Clinical relevance of predictive tests for cancer chemotherapy. Cancer Treat Rev (1982) 1.16
Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma. Cancer Res (1985) 1.15
Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance. Int J Cancer (1999) 1.10
Depressive action of serum of partially hepatectomized rats on tumour cells in vitro. Eur J Cancer (1967) 1.08
Tumour induction in the rodent Mastomys natalensis by activation of endogenous papilloma virus genomes. Nature (1984) 1.05
DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior. Cytometry (1985) 1.04
Glucose-related protein (GRP78) and its relationship to the drug-resistance proteins P170, GST-pi, LRP56 and angiogenesis in non-small cell lung carcinomas. Anticancer Res (2000) 1.02
Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma. Cancer (1985) 1.00
Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors. Anticancer Res (1990) 0.98
[Selective tumour chemotherapy using oncobiograms (author's transl)]. Dtsch Med Wochenschr (1974) 0.97
Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas. Br J Cancer (1997) 0.96
Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. Anticancer Res (1997) 0.95
Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas. Eur J Cancer (1997) 0.94
Growth of human bronchial carcinomas in nude mice. Br J Cancer (1985) 0.93
Human tumor xenografts as model for drug testing. Cancer Metastasis Rev (1988) 0.93
[Possibilities and limits of pre-therapeutic neoplasm sensitivity cytostatics tests under short-term conditions]. Schweiz Med Wochenschr (1975) 0.93
Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma. Anticancer Res (1996) 0.92
Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction. Clin Cancer Res (2001) 0.92
[Quick method for sensitivity tests of malignant tumors against antineoplastic agents]. Klin Wochenschr (1970) 0.90
Detection of drug resistance and P-glycoprotein in human renal cell carcinomas. Eur Urol (1990) 0.90
Overexpression of oncoproteins in non-small cell lung carcinomas of smokers. Carcinogenesis (1993) 0.90
Vascular endothelial growth-factor expression and angiogenesis in nonsmall cell lung carcinomas. Int J Oncol (1995) 0.89
Incorporation of 131 iododeoxyuridine into the DNA of tumour-bearing rats after partial synchronization as a tool in scintigraphic tumour localization. Nucl Med (Stuttg) (1974) 0.89
Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro. Anticancer Res (1997) 0.88
Clinical correlates of in vitro effect of adriamycin on advanced lung carcinoma. Klin Wochenschr (1976) 0.88
Relationship between the expression of caspase-3 and the clinical outcome of patients with non-small cell lung cancer. Anticancer Res (2000) 0.87
Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival. Br J Cancer (2000) 0.87
Use of tritiated nucleotide incorporation for prediction of sensitivity of tumors to cytostatic agents. Behring Inst Mitt (1984) 0.86
Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinomas. Anticancer Res (1999) 0.86
Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRB, p16INK4A) in childhood acute lymphoblastic leukemia. Int J Cancer (1997) 0.86
PD-ECGF, bFGF, and VEGF expression in non-small cell lung carcinomas and their association with lymph node metastasis. Anticancer Res (1999) 0.86
Clinical implications of cyclins, cyclin-dependent kinases, RB and E2F1 in squamous-cell lung carcinoma. Int J Cancer (1998) 0.86
Protein expression profiles indicative for drug resistance of non-small cell lung cancer. Br J Cancer (2002) 0.85
Concurrent paclitaxel and radiation therapy for breast cancer. Semin Radiat Oncol (1999) 0.85
Association of vascular endothelial growth factor expression with tumor cell proliferation in ovarian carcinoma. Anticancer Res (1997) 0.85
Messenger RNA expression of resistance proteins and related factors in human ovarian carcinoma cell lines resistant to doxorubicin, taxol and cisplatin. Anticancer Drugs (1997) 0.85
[Incorporation of a 131-iodine-deoxycytidine monophosphate protamine complex into the DNA of tumor-bearing rats following partial synchronization with hydroxyurea]. Nucl Med (Stuttg) (1975) 0.84
Isopycnic density-gradient centrifugation: a separation parameter which improves flow cytometric measurements on heterogeneous tumors. Cytometry (1983) 0.84
Sensitivity tests of tumors to cytostatic agents. I. Comparative investigations on transplanted tumors in vivo and in vitro. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1975) 0.84
Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer. Int J Cancer (1996) 0.84
O6-methylguanine-DNA methyltransferase activity and sensitivity to cyclophosphamide and cisplatin in human lung tumor xenografts. Int J Cancer (1998) 0.84
Kinetic complexity of nuclear poly(A)-containing RNA in normal and regenerating rat liver. Eur J Biochem (1979) 0.84
Occurrence of a multidrug-resistant phenotype in human lung xenografts. Br J Cancer (1987) 0.83
Sensitivity tests of tumors to cytostatic agents. II. Investigation on human tumors. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1975) 0.82
Resistance to doxorubicin in tumor cells in vitro and in vivo after pretreatment with verapamil. Chemotherapy (1991) 0.82
Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia. Anticancer Res (1999) 0.82
Reversal of doxorubicin-resistance in sarcoma 180 tumor cells by inhibition of different resistance mechanisms. Cancer Lett (1993) 0.82
[Individual chemotherapy of solid tumors]. Med Welt (1976) 0.82
Angiogenesis and cigarette smoking in squamous cell lung carcinomas: an immunohistochemical study of 28 cases. Anticancer Res (1999) 0.81
Expression of lung resistance-related protein (LRP) in non-small cell lung carcinomas of smokers and non-smokers and its predictive value for doxorubicin resistance. Anticancer Drugs (1997) 0.81
Up-regulation of resistance-related proteins in human lung tumors with poor vascularization. Carcinogenesis (1995) 0.81
Expression of lung resistance-related protein (LRP) in initial and relapsed childhood acute lymphoblastic leukemia. Anticancer Drugs (1997) 0.81
Overexpression of P-glycoprotein in human lung carcinoma xenografts after fractionated irradiation in vivo. Radiat Res (1991) 0.80
P-glycoprotein and glutathione S-transferase pi in childhood acute lymphoblastic leukaemia. Br J Cancer (1994) 0.80
Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia. Anticancer Drugs (1997) 0.80
Biological characterization of subgroups of squamous cell lung carcinomas. Clin Cancer Res (1999) 0.80
Reversal of doxorubicin-resistance in solid tumors by clomipramine. In Vivo (1995) 0.80
[Effect of carcinogenic nitrosamines and nitrosamides on the incroporation of 3H-thymidine, 3H-uridine and 3H-leucine into Tetrahymena, L-cells and liver explants]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.80
Different growth rates of lung tumours in man and their xenografts in nude mice. Eur J Cancer (1980) 0.80
Rapid screening of macromolecular synthesis in single cell cultures. Naturwissenschaften (1968) 0.79
Growth kinetics of human lung tumours in nude mice. Exp Cell Biol (1981) 0.79
Expression of heat shock proteins, glutathione peroxidase and catalase in childhood acute lymphoblastic leukemia and nephroblastoma. Cancer Lett (1996) 0.79
The effects of cytostatic drugs on transplanted tumours. An investigation of the correlation between in vivo and in vitro results. Arch Geschwulstforsch (1974) 0.79
Expression of metallothionein in initial and relapsed childhood acute lymphoblastic leukemia. Ann Hematol (1994) 0.79
Maintenance of morphology and tumour marker production in human epidermoid lung carcinoma xenografts. In Vivo (1992) 0.79
In-vitro testing of cyclophosphamide on tumors. Naturwissenschaften (1975) 0.79
[Sensitivity tests of human malignant tumors to cytostatic drugs]. Klin Wochenschr (1971) 0.79
Microvessel density and vascular endothelial growth factor expression in human tumors of different localization. Oncol Rep (1996) 0.79
nm23-H1 protein expression in newly diagnosed and relapsed childhood acute lymphoblastic leukemia. Anticancer Res (1999) 0.79
Flow cytometric analysis of primary lung carcinomas and their lymph node metastases. Anticancer Res (1987) 0.78
Expression of resistance-related proteins in tumoral and peritumoral tissues of patients with lung cancer. Cancer Lett (1996) 0.78
[Sensitivity testing of malignant human tumors against cytostatic agents. II]. Klin Wochenschr (1972) 0.78
Messenger RNA expression of resistance factors and their correlation to the proliferative activity in childhood acute lymphoblastic leukemia. Cancer Lett (1995) 0.78
Changes in the concentrations of elements in liver after partial hepatectomy. Experientia (1974) 0.78
Association between nm23-H1 expression, proliferation and apoptosis in non-small cell lung carcinomas. Clin Exp Metastasis (1998) 0.78
Influence of hormone therapy on human lung tumors transplanted into nude mice. Oncology (1985) 0.78
Predicting chemosensitivity of tumors. Breast Cancer Res Treat (1986) 0.78
Apoptotic index, Fas and bcl-2 in initial and relapsed childhood acute lymphoblastic leukaemia. Apoptosis (1997) 0.78
Taxanes in adjuvant and neoadjuvant therapies for breast cancer. Oncology (Williston Park) (1998) 0.78
Vascular liver tumors induced in Mastomys (Praomys) natalensis by single or twofold administration of dimethylnitrosamine. J Natl Cancer Inst (1979) 0.78
Albumin messenger RNA after partial hepatectomy and sham operation. Biochim Biophys Acta (1980) 0.78
Multiple resistance mechanisms in acute nonlymphoblastic leukemia (ANLL). Anticancer Res (1998) 0.78
Differential expression of intermediate-filament proteins in murine sarcoma 180 ascites or solid tumor. Cancer Res (1984) 0.78
Angiostatin expression in non-small cell lung cancer. Clin Cancer Res (2000) 0.78
Green tea catechins (EGCG and EGC) have modulating effects on the activity of doxorubicin in drug-resistant cell lines. Anticancer Drugs (1997) 0.78
[Prognostic significance of flow cytophotometric studies in ovarian cancer]. Geburtshilfe Frauenheilkd (1987) 0.78
[The effect of cyclophosphamide on tumors in the sensitivity-test (author's transl)]. Arch Gynakol (1975) 0.77
nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma. Br J Cancer (2000) 0.77
[Testing of the resistance of human tumours in the short-term test (author's transl)]. Klin Wochenschr (1975) 0.77